Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD [PDF]
Arvind Manoharan +2 more
openalex +1 more source
Tiotropium in Patients With Airflow Limitation According to the Fixed Ratio But Not the Lower Limit of Normal: A Secondary Analysis of the Tiotropium in Early-COPD Study. [PDF]
Zhou K +7 more
europepmc +1 more source
The Utility of Tiotropium Among Patients With COPD: An Update of a Meta-analysis of Randomized Controlled Trials (UTAC Update) [PDF]
Johann Paolo Augusto Almazar +2 more
openalex +1 more source
Impact of umeclidinium/vilanterol dual bronchodilator therapy on pulmonary function and inflammatory responses in stable COPD patients. [PDF]
Jiang R, Zhan W, Jian X, Li J.
europepmc +1 more source
Lower baseline FEV1 is associated with greater FEV1 improvement after tiotropium add-on in uncontrolled asthma. [PDF]
Shim JS, Ahn KM, Kim MH, Cho YJ.
europepmc +1 more source
Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database. [PDF]
Rui Y +6 more
europepmc +1 more source
Economic evaluation of generic inhalational bronchodilators from the Jan-Aushadi scheme versus branded alternatives. [PDF]
James J +3 more
europepmc +1 more source
P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status: Abstract P151 Table 1 [PDF]
Thomas B. Casale +6 more
openalex +1 more source
Effect of add-on therapy of tiotropium in COPD treated with theophylline
Hisamichi Aizawa
openalex +2 more sources

